Navigation Links
PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
Date:3/12/2008

BOSTON, March 12 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, has appointed Jacque Fisher as a Vice President and General Manager in the Company's Medical Communications Services business. Ms. Fisher brings more than 20 years of experience in biopharmaceutical industry marketing to PAREXEL. In this position, Ms. Fisher leads a global team of experts who assist clients in translating complex scientific information into integrated communications. She also has responsibility for overall client management and advising biopharmaceutical companies on the effectiveness of their medical communications programs.

"Today's highly regulated marketplace demands unique expertise. Clients increasingly turn to our medical communications team for an evidence-based approach to educate physicians and patients about key points of difference for products and to build a strong knowledge base among key opinion leaders," said Glenn Van Deusen, Corporate Vice President and Worldwide Head of Medical Communications Services, PAREXEL. "We expect our clients to greatly benefit from Ms. Fisher's expertise in providing strategic medical communications programs and in-depth experience with quality standards and regulatory requirements. Her leadership will help PAREXEL continue to meet the evolving medical communications needs of our clients."

"Biopharmaceutical companies must begin strategic planning and execution of medical communications in early phases of clinical development to achieve the greatest market awareness and education about their products," said Ms. Jacque Fisher. "I am pleased to join PAREXEL and work with such a high caliber team of medical communicati
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
2. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
3. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
4. PAREXEL International Announces 2-For-1 Stock Split
5. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
6. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
7. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
8. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
9. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
10. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... 2015 , ... The 2015 Market Research Report on the Global Propanol ... global Propanol market with a focus on the Chinese situation. Major companies included in ... ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The ...
(Date:7/30/2015)... KANSAS CITY, Kan. , July 30, 2015 ... PETX ), a pet therapeutics company focused on ... products for companion animals, today announced that its ... results from a dose confirmation study of AT-016, ... to Aratana for the treatment of osteoarthritis pain ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... University of Pennsylvania have developed nanowires capable of ... that data a thousand times faster than existing ... micro-drives, all using less power and space than ... in the Department of Materials Science and Engineering, ...
... (Sept. 18, 2007) -- Biomedical engineers at The University ... have announced pre-clinical test results in the September issue ... of a smart particle insulin release system that detects ... insulin to counteract them. , Designed to mimic functions ...
... will bike down the California coast to ... and help those affected by arthritis, SAN FRANCISCO, Sept. ... annual Amgen California Coast Classic,Bike Tour on Saturday, September 29 ... over eight days, aim to raise more,than $1.3 million this ...
Cached Biology Technology:Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3Smart insulin nanostructures pass feasibility test, UT study reports 2More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation 2
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/20/2015)... July 20, 2015  Acuity Market Intelligence,s latest ... Convergence of Commerce and Privacy" forecasts that between ... apps will be downloaded to smart mobile devices ... biometrics market is projected to generate more than ... the seven-year forecast period.    "Biometrics ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... items of commercially available off-the-shelf equipment for combating ... Protection Equipment Demonstration (FPED VII) at Stafford Regional ... VA, during May 19-21.Uniformed and civilian members of ... responsibilities in other federal departments and agencies, state ...
... is the next frontier in biological research.As new sequencing ... available to small laboratories. Thus, sequencing data is ... However, the computing capacity needed to analyze such ... to do. Large networks of interconnected computers, called ...
... GENEVA/LAUSANNE Researchers from the Universities of Geneva and ... have been part of a major international project to ... named L1 Dominette. Sequencing the bovine genome is now ... food production, taking into account the needs of an ...
Cached Biology News:Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration 2A genomic CluE for cloud computing 2A genomic CluE for cloud computing 3Sequencing the cow's genetic code -- a new agricultural era dawns 2
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
...
... with Annexin V-FITC to distinguish cells that ... (Annexin V positive, PI negative) from those ... or already dead (Annexin V-FITC positive, PI ... range of the spectrum using a 562-588 ...
... Mouse A-20 cells were cultured in RPMI ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Biology Products: